Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.
Identifieur interne : 000159 ( Ncbi/Checkpoint ); précédent : 000158; suivant : 000160Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.
Auteurs : G. J. Kaspers ; A. J. Veerman ; R. Pieters ; G. J. Broekema ; D. R. Huismans ; K. M. Kazemier ; A. H. Loonen ; M. A. Rottier ; C. H. Van Zantwijk ; K. H HlenSource :
- British Journal of Cancer [ 0007-0920 ] ; 1994.
Abstract
The methyl-thiazol-tetrazolium (MTT) assay is a drug resistance assay which cannot discriminate between malignant and non-malignant cells. We previously reported that samples with > or = 80% leukaemic cells at the start of culture give similar results in the MTT assay and the differential staining cytotoxicity assay, in which a discrimination between malignant and non-malignant cells can be made. However, the percentage of leukaemic cells may change during culture, which might affect the results of the MTT assay. We studied 106 untreated childhood acute lymphoblastic leukemia (ALL) samples with > or = 80% leukaemic cells at the start of culture. This percentage decreased below 80% in 28%, and below 70% in 13%, of the samples after 4 days of culture. A decrease below 70% occurred more often in case of 80-89% leukaemic cells (9/29) than in case of > or = 90% leukaemic cells at the start of culture (5/77, P = 0.0009). Samples with < 70% leukaemic cells after culture were significantly more resistant to 6 out of 13 drugs, and showed a trend towards being more resistant to two more drugs, than samples with > or = 80% leukaemic cells. No such differences were seen between samples with 70-79% and samples with > or = 80% leukaemic cells after culture. We next studied in another 30 ALL samples whether contaminating mononuclear cells could be removed by using immunoamagnetic beads. Using a beads to target cell ratio of 10:1, the percentage of leukaemic cells increased from mean 72% (s.d. 9.3%) to mean 87% (s.d. 6.7%), with an absolute increase of 2-35%. The recovery of leukaemic cells was mean 82.1% (range 56-100%, s.d. 14.0%). The procedure itself did not influence the results of the MTT assay in three samples containing only leukaemic cells. We conclude that it is important to determine the percentage of leukaemic cells at the start and at the end of the MTT assay and similar drug resistance assays. Contaminating mononuclear cells can be successfully removed from ALL samples using immunomagnetic beads. This approach may increase the number of leukaemic samples which can be evaluated for cellular drug resistance with the MTT assay or a similar cell culture drug resistance assay.
Url:
PubMed: 7981053
PubMed Central: 2033662
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000140
- to stream Pmc, to step Curation: 000140
- to stream Pmc, to step Checkpoint: 000172
- to stream Ncbi, to step Merge: 000159
- to stream Ncbi, to step Curation: 000159
Links to Exploration step
PMC:2033662Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.</title><author><name sortKey="Kaspers, G J" sort="Kaspers, G J" uniqKey="Kaspers G" first="G. J." last="Kaspers">G. J. Kaspers</name></author><author><name sortKey="Veerman, A J" sort="Veerman, A J" uniqKey="Veerman A" first="A. J." last="Veerman">A. J. Veerman</name></author><author><name sortKey="Pieters, R" sort="Pieters, R" uniqKey="Pieters R" first="R." last="Pieters">R. Pieters</name></author><author><name sortKey="Broekema, G J" sort="Broekema, G J" uniqKey="Broekema G" first="G. J." last="Broekema">G. J. Broekema</name></author><author><name sortKey="Huismans, D R" sort="Huismans, D R" uniqKey="Huismans D" first="D. R." last="Huismans">D. R. Huismans</name></author><author><name sortKey="Kazemier, K M" sort="Kazemier, K M" uniqKey="Kazemier K" first="K. M." last="Kazemier">K. M. Kazemier</name></author><author><name sortKey="Loonen, A H" sort="Loonen, A H" uniqKey="Loonen A" first="A. H." last="Loonen">A. H. Loonen</name></author><author><name sortKey="Rottier, M A" sort="Rottier, M A" uniqKey="Rottier M" first="M. A." last="Rottier">M. A. Rottier</name></author><author><name sortKey="Van Zantwijk, C H" sort="Van Zantwijk, C H" uniqKey="Van Zantwijk C" first="C. H." last="Van Zantwijk">C. H. Van Zantwijk</name></author><author><name sortKey="H Hlen, K" sort="H Hlen, K" uniqKey="H Hlen K" first="K." last="H Hlen">K. H Hlen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">7981053</idno><idno type="pmc">2033662</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033662</idno><idno type="RBID">PMC:2033662</idno><date when="1994">1994</date><idno type="wicri:Area/Pmc/Corpus">000140</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000140</idno><idno type="wicri:Area/Pmc/Curation">000140</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000140</idno><idno type="wicri:Area/Pmc/Checkpoint">000172</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000172</idno><idno type="wicri:Area/Ncbi/Merge">000159</idno><idno type="wicri:Area/Ncbi/Curation">000159</idno><idno type="wicri:Area/Ncbi/Checkpoint">000159</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.</title><author><name sortKey="Kaspers, G J" sort="Kaspers, G J" uniqKey="Kaspers G" first="G. J." last="Kaspers">G. J. Kaspers</name></author><author><name sortKey="Veerman, A J" sort="Veerman, A J" uniqKey="Veerman A" first="A. J." last="Veerman">A. J. Veerman</name></author><author><name sortKey="Pieters, R" sort="Pieters, R" uniqKey="Pieters R" first="R." last="Pieters">R. Pieters</name></author><author><name sortKey="Broekema, G J" sort="Broekema, G J" uniqKey="Broekema G" first="G. J." last="Broekema">G. J. Broekema</name></author><author><name sortKey="Huismans, D R" sort="Huismans, D R" uniqKey="Huismans D" first="D. R." last="Huismans">D. R. Huismans</name></author><author><name sortKey="Kazemier, K M" sort="Kazemier, K M" uniqKey="Kazemier K" first="K. M." last="Kazemier">K. M. Kazemier</name></author><author><name sortKey="Loonen, A H" sort="Loonen, A H" uniqKey="Loonen A" first="A. H." last="Loonen">A. H. Loonen</name></author><author><name sortKey="Rottier, M A" sort="Rottier, M A" uniqKey="Rottier M" first="M. A." last="Rottier">M. A. Rottier</name></author><author><name sortKey="Van Zantwijk, C H" sort="Van Zantwijk, C H" uniqKey="Van Zantwijk C" first="C. H." last="Van Zantwijk">C. H. Van Zantwijk</name></author><author><name sortKey="H Hlen, K" sort="H Hlen, K" uniqKey="H Hlen K" first="K." last="H Hlen">K. H Hlen</name></author></analytic><series><title level="j">British Journal of Cancer</title><idno type="ISSN">0007-0920</idno><idno type="eISSN">1532-1827</idno><imprint><date when="1994">1994</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The methyl-thiazol-tetrazolium (MTT) assay is a drug resistance assay which cannot discriminate between malignant and non-malignant cells. We previously reported that samples with > or = 80% leukaemic cells at the start of culture give similar results in the MTT assay and the differential staining cytotoxicity assay, in which a discrimination between malignant and non-malignant cells can be made. However, the percentage of leukaemic cells may change during culture, which might affect the results of the MTT assay. We studied 106 untreated childhood acute lymphoblastic leukemia (ALL) samples with > or = 80% leukaemic cells at the start of culture. This percentage decreased below 80% in 28%, and below 70% in 13%, of the samples after 4 days of culture. A decrease below 70% occurred more often in case of 80-89% leukaemic cells (9/29) than in case of > or = 90% leukaemic cells at the start of culture (5/77, P = 0.0009). Samples with < 70% leukaemic cells after culture were significantly more resistant to 6 out of 13 drugs, and showed a trend towards being more resistant to two more drugs, than samples with > or = 80% leukaemic cells. No such differences were seen between samples with 70-79% and samples with > or = 80% leukaemic cells after culture. We next studied in another 30 ALL samples whether contaminating mononuclear cells could be removed by using immunoamagnetic beads. Using a beads to target cell ratio of 10:1, the percentage of leukaemic cells increased from mean 72% (s.d. 9.3%) to mean 87% (s.d. 6.7%), with an absolute increase of 2-35%. The recovery of leukaemic cells was mean 82.1% (range 56-100%, s.d. 14.0%). The procedure itself did not influence the results of the MTT assay in three samples containing only leukaemic cells. We conclude that it is important to determine the percentage of leukaemic cells at the start and at the end of the MTT assay and similar drug resistance assays. Contaminating mononuclear cells can be successfully removed from ALL samples using immunomagnetic beads. This approach may increase the number of leukaemic samples which can be evaluated for cellular drug resistance with the MTT assay or a similar cell culture drug resistance assay.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Broekema, G J" sort="Broekema, G J" uniqKey="Broekema G" first="G. J." last="Broekema">G. J. Broekema</name><name sortKey="H Hlen, K" sort="H Hlen, K" uniqKey="H Hlen K" first="K." last="H Hlen">K. H Hlen</name><name sortKey="Huismans, D R" sort="Huismans, D R" uniqKey="Huismans D" first="D. R." last="Huismans">D. R. Huismans</name><name sortKey="Kaspers, G J" sort="Kaspers, G J" uniqKey="Kaspers G" first="G. J." last="Kaspers">G. J. Kaspers</name><name sortKey="Kazemier, K M" sort="Kazemier, K M" uniqKey="Kazemier K" first="K. M." last="Kazemier">K. M. Kazemier</name><name sortKey="Loonen, A H" sort="Loonen, A H" uniqKey="Loonen A" first="A. H." last="Loonen">A. H. Loonen</name><name sortKey="Pieters, R" sort="Pieters, R" uniqKey="Pieters R" first="R." last="Pieters">R. Pieters</name><name sortKey="Rottier, M A" sort="Rottier, M A" uniqKey="Rottier M" first="M. A." last="Rottier">M. A. Rottier</name><name sortKey="Van Zantwijk, C H" sort="Van Zantwijk, C H" uniqKey="Van Zantwijk C" first="C. H." last="Van Zantwijk">C. H. Van Zantwijk</name><name sortKey="Veerman, A J" sort="Veerman, A J" uniqKey="Veerman A" first="A. J." last="Veerman">A. J. Veerman</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/SgmlV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000159 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000159 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Informatique
|area= SgmlV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= PMC:2033662
|texte= Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:7981053" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SgmlV1
| This area was generated with Dilib version V0.6.33. |  |